Ron Baron: 36 Bio-Techne transactions (Baron Funds / TECH)

36 Ron Baron Bio-Techne Trades

Ron Baron acquired 5.35 Million Bio-Techne shares worth $433 Million. That's 1.18% of their equity portfolio (19th largest holding). The investor owns 3.45% of the outstanding Bio-Techne stock. The first Bio-Techne trade was made in Q4 2014. Since then Ron Baron bought shares thirteen more times and sold shares on 22 occasions. The investor's estimated purchase price is $1.02 Billion, resulting in a loss of 58%.

Avg closing price

Price range

Sold 0.4% shares (-24 Thousand shares) Q4 2023

Avg closing price $65.87

Price range $52.83 - $78.22

Sold 0.1% shares (-4.52 Thousand shares) Q3 2023

Avg closing price $79.00

Price range $67.52 - $89.42

Increased shares by 0.0% (+982 shares) Q2 2023

Avg closing price $80.38

Price range $73.76 - $85.98

Sold 2.5% shares (-140 Thousand shares) Q1 2023

Avg closing price $77.07

Price range $71.62 - $86.62

Increased shares by 286.7% (+4.09 Million shares) Q4 2022

Avg closing price $230.67

Price range $80.67 - $352.29

Sold 1.7% shares (-24.3 Thousand shares) Q3 2022

Avg closing price $345.64

Price range $282.54 - $391.85

Sold 1.2% shares (-17.7 Thousand shares) Q2 2022

Avg closing price $374.87

Price range $322.67 - $449.65

Sold 0.9% shares (-13.8 Thousand shares) Q1 2022

Avg closing price $412.68

Price range $353.85 - $487.79

Sold 0.7% shares (-10.9 Thousand shares) Q4 2021

Avg closing price $490.35

Price range $456.15 - $525.06

Sold 0.3% shares (-4.12 Thousand shares) Q3 2021

Avg closing price $486.80

Price range $444.87 - $538.88

Increased shares by 0.2% (+2.71 Thousand shares) Q2 2021

Avg closing price $421.02

Price range $387.35 - $450.26

Increased shares by 0.1% (+1.79 Thousand shares) Q1 2021

Avg closing price $364.91

Price range $314.62 - $411.00

Sold 0.1% shares (-1.76 Thousand shares) Q4 2020

Avg closing price $289.67

Price range $246.90 - $321.87

Sold 1.5% shares (-23.2 Thousand shares) Q3 2020

Avg closing price $260.20

Price range $232.22 - $282.96

Sold 0.5% shares (-7.89 Thousand shares) Q2 2020

Avg closing price $239.54

Price range $185.43 - $279.56

Sold 0.5% shares (-7.2 Thousand shares) Q1 2020

Avg closing price $200.09

Price range $161.17 - $221.51

Sold 2.6% shares (-41 Thousand shares) Q4 2019

Avg closing price $209.86

Price range $189.68 - $222.09

Increased shares by 0.4% (+6.23 Thousand shares) Q3 2019

Avg closing price $200.57

Price range $183.56 - $216.72

Increased shares by 0.0% (+66 shares) Q2 2019

Avg closing price $201.55

Price range $188.72 - $215.43

Increased shares by 2.2% (+34.5 Thousand shares) Q1 2019

Avg closing price $180.01

Price range $136.09 - $200.44

News about Bio-Techne Corp and Ron Baron

Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded...

Insider Monkey, 7 months ago

Ron Baron Comments on Bio-Techne

Guru stock highlight Check out Ron Baron Stock Picks » Download GuruFolio Report of Ron Baron (Updated on 11/08/2022) Related Stocks: TECH ,

GuruFocus, over 1 year ago

Baron Funds: “Bio-Techne (TECH) Can Still Generate Strong Revenue Growth”

Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.

Insider Monkey, almost 2 years ago